PAVmed Earns FDA Clearance for Carpal Tunnel Device

PAVmed’s minimally invasive CarpX carpal tunnel device has received 510(k) clearance from the FDA.

The agency granted the clearance based on a review of data from the company’s clinical trial conducted in New Zealand.

The device is the first cleared by the FDA to use catheter, balloon and wire techniques for carpal tunnel procedures.